Passage Bio, Inc. (PASG)
NASDAQ: PASG · IEX Real-Time Price · USD
0.900
+0.010 (1.10%)
At close: Jul 19, 2024, 12:00 AM
0.864
-0.036 (-3.99%)
Pre-market: Jul 22, 2024, 8:08 AM EDT
Passage Bio Employees
Passage Bio had 58 employees as of December 31, 2023. The number of employees decreased by 27 or -31.76% compared to the previous year.
Employees
58
Change (1Y)
-27
Growth (1Y)
-31.76%
Revenue / Employee
n/a
Profits / Employee
-$1,455,776
Market Cap
55.47M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 58 | -27 | -31.76% |
| Dec 31, 2022 | 85 | -48 | -36.09% |
| Dec 31, 2021 | 133 | 59 | 79.73% |
| Dec 31, 2020 | 74 | 54 | 270.00% |
| Dec 31, 2019 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Allurion Technologies | 504 |
| Cytosorbents | 186 |
| LENSAR | 130 |
| Barinthus Biotherapeutics | 130 |
| Turnstone Biologics | 80 |
| CollPlant Biotechnologies | 75 |
| Rallybio | 43 |
| Immix Biopharma | 17 |
PASG News
- 6 days ago - Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients - GlobeNewsWire
- 6 weeks ago - Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award - GlobeNewsWire
- 2 months ago - Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 3 months ago - Passage Bio to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit - GlobeNewsWire
- 5 months ago - Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 5 months ago - Passage Bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 months ago - Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - GlobeNewsWire